Biasoli I - Search Results

1

Socioeconomic inequality and short-term outcome in Hodgkin's lymphoma.

Soares A, Biasoli I, Scheliga A, Luiz RR, Costa MA, Land M, Romano S, Morais JC, Spector N. Soares A, et al. Among authors: biasoli i. Int J Cancer. 2007 Feb 15;120(4):875-9. doi: 10.1002/ijc.22417. Int J Cancer. 2007. PMID: 17131320

2

Ceftazidime plus amikacin plus teicoplanin or vancomycin in the empirical antibiotic therapy in febrile neutropenic cancer patients.

Nucci M, Biasoli I, Braggio S, Portugal R, Schaffel R, Maiolino A, Loureiro MM, Spector N, Pulcheri W. Nucci M, et al. Among authors: biasoli i. Oncol Rep. 1998 Sep-Oct;5(5):1205-9. doi: 10.3892/or.5.5.1205. Oncol Rep. 1998. PMID: 9683836 Clinical Trial.

3

Predictive value of a positive nasal swab for Aspergillus sp. in the diagnosis of invasive aspergillosis in adult neutropenic cancer patients.

Nucci M, Biasoli I, Barreiros G, Akiti T, Derossi A, Solza C, Silveira F, Spector N, Pulcheri W. Nucci M, et al. Among authors: biasoli i. Diagn Microbiol Infect Dis. 1999 Nov;35(3):193-6. doi: 10.1016/s0732-8893(99)00073-5. Diagn Microbiol Infect Dis. 1999. PMID: 10626128

4

A double-blind, randomized, placebo-controlled trial of itraconazole capsules as antifungal prophylaxis for neutropenic patients.

Nucci M, Biasoli I, Akiti T, Silveira F, Solza C, Barreiros G, Spector N, Derossi A, Pulcheri W. Nucci M, et al. Among authors: biasoli i. Clin Infect Dis. 2000 Feb;30(2):300-5. doi: 10.1086/313654. Clin Infect Dis. 2000. PMID: 10671332 Clinical Trial.

5

Application of an adapted international prognostic index for aggressive non-Hodgkin's lymphomas: good discrimination and lower survival rates in Rio de Janeiro, Brazil.

Biasoli I, Morais JC, Soares de Jesus P, Pulcheri W, Nucci M, Spector N. Biasoli I, et al. Oncol Rep. 2001 Mar-Apr;8(2):441-4. Oncol Rep. 2001. PMID: 11182071

6

Intensified ABVP chemotherapy for the primary treatment of Hodgkin's disease.

Spector N, Costa MA, Morais JC, Biasoli I, Solza C, De Fatima Gaui M, Ferreira CG, Portugal RD, Loureiro M, Nucci M, Pulcheri W. Spector N, et al. Among authors: biasoli i. Oncol Rep. 2002 Mar-Apr;9(2):439-42. Oncol Rep. 2002. PMID: 11836623

7

CD10 and Bcl-2 expression combined with the International Prognostic Index can identify subgroups of patients with diffuse large-cell lymphoma with very good or very poor prognoses.

Biasoli I, Morais JC, Scheliga A, Milito CB, Romano S, Land M, Pulcheri W, Spector N. Biasoli I, et al. Histopathology. 2005 Mar;46(3):328-33. doi: 10.1111/j.1365-2559.2005.02099.x. Histopathology. 2005. PMID: 15720419

8

p53 Expression as a prognostic indicator in Hodgkin's lymphoma.

Spector N, Milito CB, Biasoli I, Morais JC. Spector N, et al. Among authors: biasoli i. J Clin Oncol. 2005 May 1;23(13):3158-9; author reply 3159-60. doi: 10.1200/JCO.2005.05.159. J Clin Oncol. 2005. PMID: 15860883 No abstract available.

9

The prognostic value of the expression of Bcl-2, p53 and LMP-1 in patients with Hodgkin's lymphoma.

Spector N, Milito CB, Biasoli I, Luiz RR, Pulcheri W, Morais JC. Spector N, et al. Among authors: biasoli i. Leuk Lymphoma. 2005 Sep;46(9):1301-6. doi: 10.1080/10428190500126034. Leuk Lymphoma. 2005. PMID: 16109607

10

Brazilian version of the QLQ-LC13 lung cancer module of the European Organization for Research and Treatment of Cancer: preliminary reliability and validity report.

Brabo EP, Paschoal ME, Biasoli I, Nogueira FE, Gomes MC, Gomes IP, Martins LC, Spector N. Brabo EP, et al. Among authors: biasoli i. Qual Life Res. 2006 Nov;15(9):1519-24. doi: 10.1007/s11136-006-0009-9. Epub 2006 Sep 8. Qual Life Res. 2006. PMID: 16960750

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

47 results

Search Page

Filters